Clinical Research

Our team of highly trained specialists is dedicated to offering patients the most advanced treatment available for their condition through clinical research.

Relapsing Multiple Sclerosis Study – Now Enrolling

Multiple Sclerosis: Novartis EXCHANGE Study

The EXCHANGE Study is for people with advancing relapsing multiple sclerosis (RMS). Patients are eligible if:

  • they are between 18 and 65 years of age
  • have RMS (where symptoms are getting worse over time)
  • have been treated with an MS therapy (beta-interferons, glatiramer acetate, fingolimod, dimethyl fumarate, or teriflunomide) for at least three months.
  • The EXCHANGE Study will involve 6 study visits over a period of up to 6 months.

    Study Enrollment

    If you, your family member or loved one is interested in learning more about participating in this study, please contact the Study Coordinator at 520-320-2157.